Receiving a diagnosis of squamous cell carcinoma (SCC) can be an overwhelming experience, but it is important to remember ...

A woman who lost half of her nose due to an aggressive skin cancer was left too afraid to look at herself in the mirror.

A personalised mRNA vaccine developed by Moderna and Merck shows lasting benefits for patients with high-risk skin cancer.

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- A drug that harnesses the immune system to attack cancer cells has proved successful in preventing a rare and aggressive form of skin cancer from spreading to ...

A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body’s immune system to target and eliminate cancer cells appeared to reduce the ...

In a recent study published in the journal JAMA Dermatology, researchers leveraged data from a large-scale retrospective cohort to investigate the associations between nicotinamide (vitamin B3) and ...

Researchers analyzed the health records of more than 33,800 U.S. veterans diagnosed with non-melanoma skin cancer and found ...

Rory Aroa, a 33-year-old father of two young children, died from melanoma after the cancer returned and spread aggressively, ...